BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3030987)

  • 1. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
    Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
    Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transactivation of the long terminal repeat promoter of the bovine leukemia virus in infected cells].
    Bychko VV; Pumpen PP; Aprelikova ON; Mikhaĭlov VM; Tomilin NV
    Dokl Akad Nauk SSSR; 1986; 286(1):221-3. PubMed ID: 3004866
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinants from a proviral bovine leukemia virus genome corresponding to the 3' region transactivate viral LTR in NIH3T3 and non-infected FLK cells.
    Noetzel U; Bauer D; Fischer U; Rosenthal S
    Arch Exp Veterinarmed; 1990; 44(6):901-7. PubMed ID: 1966362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone regulation of bovine leukemia virus via the long terminal repeat.
    Niermann GL; Buehring GC
    Virology; 1997 Dec; 239(2):249-58. PubMed ID: 9434716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.
    Seiki M; Inoue J; Takeda T; Hikikoshi A; Sato M; Yoshida M
    Jpn J Cancer Res; 1985 Dec; 76(12):1127-31. PubMed ID: 3005203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
    Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
    Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
    Rosen CA; Sodroski JG; Kettman R; Haseltine WA
    J Virol; 1986 Mar; 57(3):738-44. PubMed ID: 3005624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BLV and HTLV-I: their unique genomic structures and evolutionary relationship.
    Sagata N; Ikawa Y
    Princess Takamatsu Symp; 1984; 15():229-40. PubMed ID: 6085845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine leukemia virus long terminal repeat: a cell type-specific promoter.
    Derse D; Caradonna SJ; Casey JW
    Science; 1985 Jan; 227(4684):317-20. PubMed ID: 2981431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.
    Derse D
    J Virol; 1987 Aug; 61(8):2462-71. PubMed ID: 3037109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.
    Zhao X; Jimenez C; Sentsui H; Buehring GC
    Virus Res; 2007 Mar; 124(1-2):113-24. PubMed ID: 17123656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine leukemia virus, a distinguished member of the human T-lymphotropic virus family.
    Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Ghysdael J; Gregroire D; Kettmann R; Mammerickx M; Marbaix G
    Princess Takamatsu Symp; 1984; 15():219-27. PubMed ID: 6100641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.
    Fujisawa J; Seiki M; Kiyokawa T; Yoshida M
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2277-81. PubMed ID: 2986109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
    Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of U3 promotor from the LTR region of bovine leukemia virus for expressing genes for antiviral antisense RNAs in cell cultures].
    Borisenko AS; Shaiakhmetov DM; Gerzilova AG; Tikhonenko TI
    Mol Gen Mikrobiol Virusol; 1994; (3):16-20. PubMed ID: 8065378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
    Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
    Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine immunodeficiency-like virus encodes factors which trans activate the long terminal repeat.
    Pallansch LA; Lackman-Smith CS; Gonda MA
    J Virol; 1992 May; 66(5):2647-52. PubMed ID: 1313891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of cloned 3'-terminal RNA region of bovine leukemia virus (BLV).
    Tsimanis A; Bichko V; Dreilina D; Meldrais J; Lozha V; Kukaine R; Gren E
    Nucleic Acids Res; 1983 Sep; 11(17):6079-87. PubMed ID: 6310526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 3' region of bovine leukemia virus genome encodes a trans-activator protein.
    Rosen CA; Sodroski JG; Willems L; Kettmann R; Campbell K; Zaya R; Burny A; Haseltine WA
    EMBO J; 1986 Oct; 5(10):2585-9. PubMed ID: 3023049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.